BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23569038)

  • 1. Prognostic value of epidermal growth factor receptor, p53 and galectin-3 expression in papillary thyroid carcinoma.
    Lee YM; Lee JB
    J Int Med Res; 2013 Jun; 41(3):825-34. PubMed ID: 23569038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G; Zhou Y; Li T; Guo J; Zhou Z
    J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
    Wu G; Wang J; Zhou Z; Li T; Tang F
    J Int Med Res; 2013 Aug; 41(4):975-83. PubMed ID: 23857157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression.
    Salajegheh A; Dolan-Evans E; Sullivan E; Irani S; Rahman MA; Vosgha H; Gopalan V; Smith RA; Lam AK
    Exp Mol Pathol; 2014 Apr; 96(2):212-8. PubMed ID: 24530443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
    Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
    Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
    Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and diagnostic significance of p53 protein expression in papillary thyroid carcinoma.
    Shin MK; Kim JW
    Asian Pac J Cancer Prev; 2014; 15(5):2341-4. PubMed ID: 24716981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.
    de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage.
    Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
    Int J Oncol; 1999 Nov; 15(5):893-8. PubMed ID: 10536170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
    Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
    Chen L; Zhu Y; Zheng K; Zhang H; Guo H; Zhang L; Wu K; Kong L; Ruan W; Hu J; Zhang X; Chen X
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
    Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma.
    Kim Y; Kim MH; Jeon S; Kim J; Kim C; Bae JS; Jung CK
    PLoS One; 2017; 12(3):e0174737. PubMed ID: 28358874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
    Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
    BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
    Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
    Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer?
    Nam JK; Jung CK; Song BJ; Lim DJ; Chae BJ; Lee NS; Park WC; Kim JS; Jung SS; Bae JS
    Am J Surg; 2012 Apr; 203(4):436-41. PubMed ID: 21803329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of galectin-3 immunostaining in fine-needle aspiration cytology specimens from papillary thyroid carcinoma is associated with favorable pathological indices.
    Kim ES; Lim DJ; Lee K; Jung CK; Bae JS; Jung SL; Baek KH; Lee JM; Moon SD; Kang MI; Cha BY; Lee KW; Son HY
    Thyroid; 2012 Dec; 22(12):1244-50. PubMed ID: 22892040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent predictors and lymph node metastasis characteristics of multifocal papillary thyroid cancer.
    Genpeng L; Jianyong L; Jiaying Y; Ke J; Zhihui L; Rixiang G; Lihan Z; Jingqiang Z
    Medicine (Baltimore); 2018 Feb; 97(5):e9619. PubMed ID: 29384841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.